Table 3.
Neuromuscular complications in four paediatric patients with severe COVID-19: neuromuscular characterisation.
| P | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
| 1st symptoms | Generalised weakness | Left hand outer border hypostesia, inability to take objects with the left hand. Daily living activities with support | Generalised weakness | Left leg and foot hypostesia and pain, left foot drop |
| 1st NM evaluation: MRC/MRC Sumscore (days after admission/days after paralysing drugs suspension) | MRC Sumscore: 6/60 (21/7) | MRC: left hand: 4/5 ulnar finger flexors/extensors (31/NP) | MRC Sumscore 28/60 (19/7) | MRC: left lower limb: knee flexors 4/5, plantar flexion 0/5, dorsiflexion 0/5 (23/10) |
| 1st EMG (days after admission) | Sensorimotor axonal neuropathy (day 21) | Left cubital neuropathy (day 148) | Generalised myopathic signs (day 19) | Left sciatic neuropathy (day 94) |
| Final NM diagnosis | Critical patient neuropathy, left brachial plexopathy | Left ulnar neuropathy | Critical patient myopathy | Left sciatic neuropathy |
| Follow-up | Day 55: left upper limb: deltoid 1/5 deltoid, 2/5 biceps. Sumscore 38/60. 2nd EMG: left brachial plexopathy 5 months: Walks two steps with support. Left deltoid. Left biceps 2/5. MRC Sumscore 51/60 |
4 months: able to take objects with the left hand. Daily living activities without support. Left hand hypostesia and weakness. left hand: 4/5 ulnar finger flexors/extensors. | 4 months: walks with support. Sumscore 60/60 | 4 months: no recovery. Walks with left steppage |
MRC: Medical Research Council, NM: neuromuscular, NP: no paralysing drugs, P: patie.